Literature DB >> 31806420

Metagenomic profiling of the pro-inflammatory gut microbiota in ankylosing spondylitis.

Chen Zhou1, Hui Zhao2, Xin-Yue Xiao1, Bei-di Chen1, Rui-Jin Guo2, Qi Wang2, Hua Chen3, Li-Dan Zhao1, Chen-Chen Zhang2, Yu-Hao Jiao1, Yan-Mei Ju2, Hua-Xia Yang3, Yun-Yun Fei3, Li Wang3, Min Shen3, Hui Li4, Xiao-Han Wang5, Xin Lu6, Bo Yang6, Jin-Jing Liu3, Jing Li3, Lin-Yi Peng3, Wen-Jie Zheng3, Chun-Yan Zhang3, Jia-Xin Zhou3, Qing-Jun Wu3, Yun-Jiao Yang3, Jin-Mei Su3, Qun Shi3, Di Wu3, Wen Zhang3, Feng-Chun Zhang3, Hui-Jue Jia2, De-Pei Liu7, Zhu-Ye Jie8, Xuan Zhang9.   

Abstract

OBJECTIVE: Gut dysbiosis has been reported implicated in ankylosing spondylitis (AS), a common chronic inflammatory disease mainly affects sacroiliac joints and spine. Utilizing deep sequencing on the feces of untreated AS patients, our study aimed at providing an in-depth understanding of AS gut microbiota.
METHODS: We analyzed the fecal metagenome of 85 untreated AS patients and 62 healthy controls by metagenomic shotgun sequencing, and 23 post-treatment feces of those AS patients were collected for comparison. Comparative analyses among different cohorts including AS, rheumatoid arthritis and Behcet's disease were performed to uncover some common signatures related to inflammatory arthritis. Molecular mimicry of a microbial peptide was also demonstrated by ELISpot assay.
RESULTS: We identified AS-enriched species including Bacteroides coprophilus, Parabacteroides distasonis, Eubacterium siraeum, Acidaminococcus fermentans and Prevotella copri. Pathway analysis revealed increased oxidative phosphorylation, lipopolysaccharide biosynthesis and glycosaminoglycan degradation in AS gut microbiota. Microbial signatures of AS gut selected by random forest model showed high distinguishing accuracy. Some common signatures related to autoimmunity, such as Bacteroides fragilis and type III secretion system (T3SS), were also found. Finally, in vitro experiments demonstrated an increased amount of IFN-γ producing cells triggered by a bacterial peptide of AS-enriched species, mimicking type II collagen.
CONCLUSIONS: These findings collectively indicate that gut microbiota was perturbed in untreated AS patients with diagnostic potential, and some AS-enriched species might be triggers of autoimmunity by molecular mimicry. Additionally, different inflammatory arthritis shared some common microbial signatures.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Ankylosing spondylitis; Diagnostic marker; Gut microbiota; Inflammatory arthritis; Molecular mimicry

Mesh:

Substances:

Year:  2019        PMID: 31806420     DOI: 10.1016/j.jaut.2019.102360

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  31 in total

Review 1.  Gut Microbiota in Lupus: a Butterfly Effect?

Authors:  Rongli Li; Xia Meng; Beidi Chen; Lidan Zhao; Xuan Zhang
Journal:  Curr Rheumatol Rep       Date:  2021-04-16       Impact factor: 4.592

Review 2.  Probiotic supplementation demonstrates therapeutic potential in treating gut dysbiosis and improving neurocognitive function in age-related dementia.

Authors:  Henry Yue Hong Meng; Christopher Chi Hang Mak; Wing Yan Mak; Tao Zuo; Ho Ko; Francis Ka Leung Chan
Journal:  Eur J Nutr       Date:  2022-01-10       Impact factor: 5.614

3.  In vitro triple coculture with gut microbiota from spondyloarthritis patients is characterized by inter-individual differences in inflammatory responses.

Authors:  Marta Calatayud Arroyo; Tom Van de Wiele; Annelore Beterams; Kim De Paepe; Ann-Sophie De Craemer; Dirk Elewaut; Koen Venken
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

Review 4.  The Role of Intestinal Mucosal Barrier in Autoimmune Disease: A Potential Target.

Authors:  Jia An; Yuqing Liu; Yiqi Wang; Ru Fan; Xiaorong Hu; Fen Zhang; Jinhua Yang; Junwei Chen
Journal:  Front Immunol       Date:  2022-07-01       Impact factor: 8.786

Review 5.  Ankylosing spondylitis: an autoimmune or autoinflammatory disease?

Authors:  Daniele Mauro; Ranjeny Thomas; Giuliana Guggino; Rik Lories; Matthew A Brown; Francesco Ciccia
Journal:  Nat Rev Rheumatol       Date:  2021-06-10       Impact factor: 20.543

6.  Exploration of Crucial Mediators for Carotid Atherosclerosis Pathogenesis Through Integration of Microbiome, Metabolome, and Transcriptome.

Authors:  Lei Ji; Siliang Chen; Guangchao Gu; Jiawei Zhou; Wei Wang; Jinrui Ren; Jianqiang Wu; Dan Yang; Yuehong Zheng
Journal:  Front Physiol       Date:  2021-05-24       Impact factor: 4.566

Review 7.  Parabacteroides distasonis: intriguing aerotolerant gut anaerobe with emerging antimicrobial resistance and pathogenic and probiotic roles in human health.

Authors:  Jessica C Ezeji; Daven K Sarikonda; Austin Hopperton; Hailey L Erkkila; Daniel E Cohen; Sandra P Martinez; Fabio Cominelli; Tomomi Kuwahara; Armand E K Dichosa; Caryn E Good; Michael R Jacobs; Mikhail Khoretonenko; Alida Veloo; Alexander Rodriguez-Palacios
Journal:  Gut Microbes       Date:  2021 Jan-Dec

8.  Probiotic Supplementation Improves Cognitive Function and Mood with Changes in Gut Microbiota in Community-Dwelling Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial.

Authors:  Chong-Su Kim; Lina Cha; Minju Sim; Sungwoong Jung; Woo Young Chun; Hyun Wook Baik; Dong-Mi Shin
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2021-01-01       Impact factor: 6.053

Review 9.  Gut Microbiome in Psoriasis: An Updated Review.

Authors:  Mariusz Sikora; Albert Stec; Magdalena Chrabaszcz; Aleksandra Knot; Anna Waskiel-Burnat; Adriana Rakowska; Malgorzata Olszewska; Lidia Rudnicka
Journal:  Pathogens       Date:  2020-06-12

Review 10.  Crosstalk Between Gut Microbiota and Innate Immunity and Its Implication in Autoimmune Diseases.

Authors:  Yuhao Jiao; Li Wu; Nicholas D Huntington; Xuan Zhang
Journal:  Front Immunol       Date:  2020-02-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.